Search for:

Clinical Trials
Investors & Media
Careers
Contact Us

Our Focus
Our Research
Our Medicine
Our Story
- Timeline
- Leadership
- Board
- Locations
  - Corporate Offices (US and UK)
  - Austria
  - Belgium
  - Canada
  - Denmark
  - Finland
  - France
  - Germany
  - Iceland
  - Ireland
  - Italy
  - Luxembourg
  - The Netherlands
  - Norway
  - Portugal
  - Spain
  - Sweden
  - Switzerland
  - United Kingdom
Careers
Contact Us

Home > Our Research > Clinical Trials

We're currently enrolling for

CLINICAL TRIALS

Our Focus
Our Research
Our Medicine
Our Story
- Timeline
- Leadership
- Board
- Locations
  - Corporate Offices (US and UK)
  - Austria
  - Belgium
  - Canada
  - Denmark
  - Finland
  - France
  - Germany
  - Iceland
  - Ireland
  - Italy
  - Luxembourg
  - The Netherlands
  - Norway
  - Portugal
  - Spain
  - Sweden
  - Switzerland
  - United Kingdom
Careers
Contact Us

NASH

A phase 3 clinical study for patients with nonalcoholic steatohepatitis (NASH) fibrosis

A phase 3 clinical study for patients with NASH cirrhosis

PBC

A phase 4 clinical study for patients with primary biliary cholangitis (PBC)

Biliary Atresia

A phase 2 clinical study for patients with biliary atresia

Privacy Policy
Privacy Shield Policy
Corporate Compliance
Terms of Use
Contact Us

10 Hudson Yards, 37th Floor|New York, NY 10001|T: 844-782-ICPT
© 2019 Intercept Pharmaceuticals, Inc.

YOU ARE NOW leaving interceptpharma.com

You are now leaving Intercept Pharmaceuticals’ corporate website and entering a site intended for U.S. audiences only.

YOU ARE NOW leaving interceptpharma.com

The link you have selected will take you outside of Intercept Pharmaceuticals’ corporate website.
The site you will be entering is intended for U.S. audiences only.

If you are a healthcare provider looking for product information, visit ocalivahcp.com.

YOU ARE NOW leaving interceptpharma.com

You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. Intercept provides this link as a service to its website visitors. Intercept is not responsible for the content or the privacy policy of any third party websites.

Close this window to return to Intercept Pharmaceuticals’ site or click ‘Continue’ to proceed.

United States (US)
European Union (EU)
Canada
Israel
Switzerland
Australia
Liechtenstein
United Arab Emirates (UAE)

This website uses cookies. These cookies allow us to recognize, distinguish and count the number of visitors to our site, helping us to provide you with a good experience while browsing our website. Please check the box to acknowledge the use of cookies. To find out more about this, please see our privacy policy.